About
This section provides supporting information for the Kcentra Dosing Calculator. Kcentra (Prothrombin Complex Concentrate, Human) is indicated for the urgent reversal of acquired coagulation factor deficiency induced by Vitamin K antagonist (VKA, e.g., warfarin) therapy in adult patients with acute major bleeding or the need for an urgent surgery/invasive procedure. This guide outlines the calculator’s parameters and the principles behind its outputs.
Outputs
After entering the required patient data, the calculator provides a comprehensive dosing and administration plan, including:
- Total Kcentra Dose: The final calculated dose in International Units (IU), adjusted for the relevant maximum dose cap based on INR.
- Vials Required: The recommended combination of 500 IU and 1000 IU vials needed to prepare the total dose.
- Total Volume for Infusion: The final volume in milliliters (mL) after reconstituting the required vials (20 mL for 500 IU vials, 40 mL for 1000 IU vials).
- Infusion Rates: The weight-based initial rate (for the first 10 minutes) and the subsequent rate for the remainder of the infusion, capped at maximums for patient safety.
- Estimated Infusion Duration: The approximate total time in minutes to complete the infusion.
How to use
To use the calculator, follow these simple steps:
- Enter Patient Weight: Input the patient’s actual body weight and select the appropriate unit (kg or lbs).
- Enter Pre-treatment INR: Input the most recent International Normalized Ratio (INR) value obtained before the planned Kcentra administration.
- Calculate: The tool will automatically calculate and display the complete dosing and administration plan. All calculations must be independently verified.
Dosing overview
Kcentra dosing is individualized based on the patient’s actual body weight and pre-treatment INR, as per the prescribing information. The calculator uses the following FDA-approved dosing tiers:
- INR 2 to <4: Dose is 25 IU of Factor IX per kg body weight. (Maximum dose: 2500 IU)
- INR 4 to 6: Dose is 35 IU of Factor IX per kg body weight. (Maximum dose: 3500 IU)
- INR >6: Dose is 50 IU of Factor IX per kg body weight. (Maximum dose: 5000 IU)
The dose is based on the Factor IX content. Each vial is reconstituted to a final concentration of approximately 25 IU/mL. The maximum rate of infusion should not exceed 5.0 mL/min, as reflected in the calculator’s capped rate outputs.
Switching
Kcentra is an acute, on-demand treatment for urgent VKA reversal. It is not used for chronic therapy or prophylaxis. Therefore, concepts like switching between maintenance medications or routine dose adjustments are not applicable to its administration.
Missed dose
Kcentra is administered as a single, complete intravenous infusion based on immediate clinical need for VKA reversal. It is not on a recurring schedule, so the concept of a “missed dose” does not apply.
Safety alerts
Boxed Warning: Patients being treated with VKA therapy have underlying disease states that predispose them to thromboembolic events. Kcentra may increase the risk of arterial and venous thromboembolic complications. Monitor patients for signs and symptoms of thromboembolic events. Kcentra is contraindicated in patients with Disseminated Intravascular Coagulation (DIC) and in patients with known heparin-induced thrombocytopenia (HIT). Always consult the full prescribing information for complete safety details.
FAQ
1. What happens if the calculated dose falls between standard vial sizes?
The calculator determines the combination of 500 IU and 1000 IU vials that meets or exceeds the calculated dose, ensuring the full therapeutic dose is available for administration.
2. Why is there a maximum dose for each INR range?
The maximum dose caps (e.g., 2500 IU for INR 2 to <4) are specified in the official prescribing information to balance the therapeutic benefit of VKA reversal with the potential risk of thromboembolic events.
3. Should I use actual or ideal body weight for obese patients?
The Kcentra prescribing information specifies dosing is based on the patient’s actual body weight. The calculator uses the weight entered for all calculations.
4. What if the patient’s INR is below 2.0?
The calculator will display a message indicating that Kcentra is not indicated for patients with a pre-treatment INR below 2.0.
5. How is the infusion rate determined?
The rate is weight-based, starting at 0.12 mL/kg/min (capped at 2.5 mL/min) for 10 minutes, then increasing to 0.24 mL/kg/min (capped at 5.0 mL/min) for the remainder of the infusion, per the product label.
6. Can this calculator be used for other prothrombin complex concentrates (PCCs)?
No. This tool is specifically designed for Kcentra. Other PCC products have different formulations, concentrations, and dosing recommendations.
7. Does the calculator account for the administration of Vitamin K?
No. The tool only calculates the Kcentra dose. Co-administration of Vitamin K is recommended to maintain sustained INR reversal, but the decision and dose must be determined separately by the treating clinician.
8. What is the final concentration of reconstituted Kcentra?
Kcentra is reconstituted to a final concentration of approximately 25 IU/mL. A 500 IU vial is mixed with 20 mL of sterile water, and a 1000 IU vial is mixed with 40 mL.
References
- Kcentra – U.S. Food and Drug Administration (FDA). Official prescribing information and product approvals.
- KcentraHCP.com. Official manufacturer website for U.S. healthcare professionals.
- Tomaselli, G. F., et al. (2020). 2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants. Journal of the American College of Cardiology, 76(5), 594-622.
- Schulman, S., & Cuker, A. (2020). How I treat bleeding in patients receiving direct oral anticoagulants. Blood, 136(11), 1264-1272.
